Research ArticleArticle
Sch 50971, an Orally Active Histamine H3 Receptor Agonist, Inhibits Central Neurogenic Vascular Inflammation and Produces Sedation in the Guinea Pig
R. L. McLeod, R. Aslanian, M. del Prado, R. Duffy, R. W. Egan, W. Kreutner, R. McQuade and J. A. Hey
Journal of Pharmacology and Experimental Therapeutics October 1998, 287 (1) 43-50;
R. L. McLeod
R. Aslanian
M. del Prado
R. Duffy
R. W. Egan
W. Kreutner
R. McQuade

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 287, Issue 1
1 Oct 1998
Research ArticleArticle
Sch 50971, an Orally Active Histamine H3 Receptor Agonist, Inhibits Central Neurogenic Vascular Inflammation and Produces Sedation in the Guinea Pig
R. L. McLeod, R. Aslanian, M. del Prado, R. Duffy, R. W. Egan, W. Kreutner, R. McQuade and J. A. Hey
Journal of Pharmacology and Experimental Therapeutics October 1, 1998, 287 (1) 43-50;
Research ArticleArticle
Sch 50971, an Orally Active Histamine H3 Receptor Agonist, Inhibits Central Neurogenic Vascular Inflammation and Produces Sedation in the Guinea Pig
R. L. McLeod, R. Aslanian, M. del Prado, R. Duffy, R. W. Egan, W. Kreutner, R. McQuade and J. A. Hey
Journal of Pharmacology and Experimental Therapeutics October 1, 1998, 287 (1) 43-50;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement